World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , 

World Journal of Pharmaceutical
and Medical Research

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 4.103

ICV : 56.51

Abstract

DIRECT- ACTING ANTI- HEPATITIS C AGENTS AND THE RISK OF HEPATOCELLULAR CARCINOMA DEVELOPMENT VS THE OLD AGENTS: DOES THE OLD STILL THE GOLD?

Erwa Elmakki*

ABSTRACT

Direct acting anti-viral (DAA) are the newest medications used for treatment of Chronic hepatitis C (CHC). DAA agents were approved by the American Food and Drug Administration (FDA) in 2014 as a novel treatment for CHC.[1] Commonly used DAA regimens include: Sofosbuvir plus Semiprevir or Ledipasvir for hepatitis C virus (HCV) genotype 1, and Sofosbuvir plus Velpatasvir for all HCV genotypes.

[Full Text Article]

Powered By WJPMR | All Right Reserved

WJPMR